title: Failure to detect the 22q11.2 duplication syndrome rearrangement among patients with schizophrenia.
abstract: Chromosome aberrations have long been studied in an effort to identify susceptibility genes for schizophrenia. Chromosome 22q11.2 microdeletion is associated with DiGeorge and Velocardiofacial syndromes (DG/VCF) and provides the most convincing evidence of an association between molecular cytogenetic abnormality and schizophrenia. In addition, this region is one of the best replicated linkage findings for schizophrenia. Recently, the reciprocal microduplication on 22q11.2 has been reported as a new syndrome. Preliminary data indicates that individuals with these duplications also suffer from neuropsychiatric disorders. In this study we have investigated the appropriateness of testing schizophrenia patients for the 22q11.2 microduplication. We used multiplex ligation-dependent probe amplification (MLPA) to measure copy number changes on the 22q11.2 region in a sample of 190 patients with schizophrenia. Our results corroborate the prevalence of the 22q11.2 microdeletion in patients with schizophrenia and clinical features of DG/VCFS and do not suggest an association between 22q11.2 microduplication and schizophrenia.
authors.affiliation: Genes and Disease Program, Barcelona Genotyping Node, CeGen-CRG, CIBER en Epidemiología y Salud Pública (CIBERESP), Center for Genomic Regulation (CRG-UPF), Barcelona, Catalonia, Spain. xavier.estivill@crg.es.
authors.forename: Anna
authors.initials: A
authors.lastname: Brunet
authors.forename: Lluís
authors.initials: L
authors.lastname: Armengol
authors.forename: Trini
authors.initials: T
authors.lastname: Pelaez
authors.forename: Roser
authors.initials: R
authors.lastname: Guillamat
authors.forename: Vicenç
authors.initials: V
authors.lastname: Vallès
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Gabau
authors.forename: Xavier
authors.initials: X
authors.lastname: Estivill
authors.forename: Miriam
authors.initials: M
authors.lastname: Guitart